NCT01285349

Brief Summary

This randomized controlled trial is designed to address gaps in couple-based HIV prevention research by focusing exclusively on HIV negative concordant couples where one or both partners are drug-involved. Building on prior couple-based HIV research that resulted in an evidence-based HIV prevention model for couples (Connect), intervention components were modified to address dyadic drug risk reduction and drug-related unsafe sex and a couple-based HIV risk reduction intervention (Connect II) was designed specifically for drug-involved, HIV negative concordant heterosexual couples at risk for HIV/STIs. For this RCT, couples are recruited primarily through street outreach in drug using locations and randomized into one of three arms: (1) couple-based HIV Risk Reduction condition; (2) individual-based HIV Risk Reduction, which delivered the same content as the couple-based condition but was provided to either the male or female drug-using partner alone; or (3) couple-based Wellness Promotion, which served as an attentional control arm. This RCT tests two major hypotheses: (1) whether the HIV risk reduction intervention provided to the couple or an individual partner would be more efficacious in decreasing number of unprotected acts of intercourse and having a lower cumulative incidence of biologically confirmed STIs over the 12-month follow-up period compared to the Wellness promotion control arm and (2) whether the couple-based HIV risk reduction intervention would be more likely to decrease the number of unprotected acts and have a lower cumulative STI incidence compared to the Individual HIV Risk reduction Arm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
564

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 28, 2011

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
6.2 years until next milestone

Results Posted

Study results publicly available

January 14, 2019

Completed
Last Updated

January 14, 2019

Status Verified

July 1, 2018

Enrollment Period

3.9 years

First QC Date

January 21, 2011

Results QC Date

July 31, 2013

Last Update Submit

July 18, 2018

Conditions

Keywords

HIV, STI, condom use, drug use,

Outcome Measures

Primary Outcomes (1)

  • Number of Unprotected Acts of Intercourse

    90 days

Secondary Outcomes (1)

  • Number of Participants With Biologically Confirmed STIs (i.e., Chlamydia, Gonorrhea, and Trichomoniasis)

    past 12 months

Study Arms (3)

Couple-based HIV prevention

EXPERIMENTAL

7-session couple-based HIV/STI risk reduction intervention (CSTI)

Behavioral: Couple HIV/STI prevention interventionBehavioral: Couple-based HIV/STI prevention

Individual HIV/STI Prevention

ACTIVE COMPARATOR

7-session individual HIV/STI intervention comparison condition (ISTI) provided to the index participant alone, which is identical in content to the CSTI.

Behavioral: Individual HIV/STI prevention

Couple Wellness Promotion

PLACEBO COMPARATOR

7-session couple-based stress reduction intervention (CSR) that serves as an attentional control condition.

Behavioral: Couple Wellness Promotion

Interventions

Couple-based HIV prevention
Couple-based HIV prevention
Individual HIV/STI Prevention
Couple Wellness Promotion

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Couples were eligible to participate if:
  • Both were 18 and older and at least one partner was 18-40
  • Both tested HIV negative using Oratest procedures
  • Both identified each other as main, regular partner, boy/girlfriend, spouse, lover
  • Both reported that they have been together for at least 6 months
  • Both intended to remain together for at least one year
  • At least one partner reported using illicit drugs in the prior 90 days and was seeking or in drug treatment
  • At least one partner reported having had unprotected intercourse with the other in the prior 90 days.
  • Additionally, at least one partner had to report one or more of the following HIV risk criteria:
  • Having had sex with other partners in the prior 90 days
  • Injecting drugs in the prior 90 days; or
  • Self-report being diagnosed with an STI in the prior 90 days.

You may not qualify if:

  • Couples were excluded from the study:
  • If either partner reported experiencing severe intimate partner violence in the past year by the other partner as assessed by subscales of the Revised Conflict Tactics Scale
  • If either partner exhibited a severe cognitive or psychiatric impairment assessed during informed consent
  • If either partner did not have sufficient understanding of English
  • If either partner reported intentions to have a baby in the next year and to relocate beyond a reasonable distance from the study site in the coming year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Social Intervention Group/Columbia University School of Social Work

New York, New York, 10027, United States

Location

Related Publications (1)

  • El-Bassel N, Gilbert L, Wu E, Witte SS, Chang M, Hill J, Remien RH. Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):198-206. doi: 10.1097/QAI.0b013e318229eab1.

MeSH Terms

Conditions

Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Nabila El-Bassel
Organization
Social Intervention Group

Study Officials

  • Louisa Gilbert, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Research Scientist in the Faculty of Social Work , Adjunct Assistant Professor of Social Work

Study Record Dates

First Submitted

January 21, 2011

First Posted

January 28, 2011

Study Start

November 1, 2005

Primary Completion

October 1, 2009

Study Completion

November 1, 2012

Last Updated

January 14, 2019

Results First Posted

January 14, 2019

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will share

Data from this study is currently available for public use. Requests to use data should be made to the PI, Louisa Gilbert (lg123@columbia.edu)

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data is currently available.
Access Criteria
Please contact PI for sharing access. Data are available for public use.

Locations